iqvia glp 1 GLP-1 Use Linked to Nutritional Gaps in Patients | Consumer Health posted on the topic GLP-1 Treatments Boost Obesity Management

Cleveland Clinic researchers presented a propensity-matched analysis of 10,225 patients who initiated GLP-1 receptor agonist therapy (semaglutide or tirzepatide

There are promising findings from laboratory studies and early observational reports, but the evidence base is thinner

Although the precise mechanism remains unknown, GLP-1 deficiency may alter K-cell function, leading to compensatory hypersecretion of GIP, as previously suggested (Iida et al., 2016)

Who Uses Semaglutide

& Hiasa, M

Tirzepatide runs ~$349/month , or ~$299/month on a 3-month supply competitive for tirzepatide, which typically costs more than semaglutide across most platforms